Rafferty Asset Management, LLC Ligand Pharmaceuticals Inc Transaction History

Rafferty Asset Management, LLC

$28.9 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.01 - $107.56 $83 - $894,253	8,314 Added 29.68%	36,330 $3.13 Million
Q2 2022 Aug 12, 2022	SELL	$74.52 - $117.06 $1.48 Million - $2.32 Million	-19,804 Reduced 41.41%	28,016 $2.5 Million
Q1 2022 May 13, 2022	BUY	$94.99 - $151.56 $1.06 Million - $1.7 Million	11,187 Added 30.54%	47,820 $5.38 Million
Q4 2021 Feb 10, 2022	BUY	$127.69 - $165.85 $1.77 Million - $2.3 Million	13,867 Added 60.91%	36,633 $5.66 Million
Q3 2021 Nov 10, 2021	BUY	$102.33 - $144.73 $170,379 - $240,975	1,665 Added 7.89%	22,766 $3.17 Million
Q2 2021 Aug 10, 2021	BUY	$113.03 - $155.64 $99,918 - $137,585	884 Added 4.37%	21,101 $2.77 Million
Q1 2021 May 10, 2021	BUY	$99.52 - $215.83 $1.01 Million - $2.2 Million	10,176 Added 101.34%	20,217 $3.08 Million
Q4 2020 Feb 10, 2021	SELL	$80.55 - $106.05 $761,680 - $1 Million	-9,456 Reduced 48.5%	10,041 $999,000
Q3 2020 Nov 13, 2020	BUY	$89.56 - $126.72 $895,958 - $1.27 Million	10,004 Added 105.38%	19,497 $1.86 Million
Q2 2020 Aug 07, 2020	BUY	$68.28 - $123.65 $351,095 - $635,808	5,142 Added 118.18%	9,493 $1.06 Million
Q1 2020 May 15, 2020	SELL	$63.37 - $107.88 $2.07 Million - $3.52 Million	-32,648 Reduced 88.24%	4,351 $316,000
Q4 2019 Feb 10, 2020	SELL	$96.94 - $113.59 $2.86 Million - $3.35 Million	-29,529 Reduced 44.39%	36,999 $3.86 Million
Q3 2019 Nov 14, 2019	BUY	$86.25 - $120.16 $1.57 Million - $2.18 Million	18,171 Added 37.58%	66,528 $6.62 Million
Q2 2019 Aug 09, 2019	BUY	$107.38 - $129.34 $165,365 - $199,183	1,540 Added 3.29%	48,357 $5.52 Million
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $4.96 Million - $6.67 Million	46,817 New	46,817 $5.89 Million

Others Institutions Holding LGND

# of Institutions

255

Shares Held

18.1M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.86B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.

Account